搜索





搜索





市场行情
/
股票
/
mirm
/

Mirum Pharmaceuticals Inc

MIRM

添加自选

105.950USD

-6.640-5.90%

收盘 07-31 16:00（美东）报价延迟15分钟

5.50B总市值

亏损市盈率 TTM

Mirum Pharmaceuticals Inc

105.950

-6.640-5.90%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

MIRM 利润表

您可以在这里找到Mirum Pharmaceuticals Inc的年度或季度收入报告，以深入了解Mirum Pharmaceuticals Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

营业总收入

43.28%159.88M

49.81%148.93M

47.17%133.01M

64.09%127.78M

61.20%111.58M

42.93%99.41M

89.37%90.38M

107.68%77.88M

119.07%69.22M

149.24%69.55M

154.13%47.73M

114.46%37.50M

145.10%31.60M

789.29%27.91M

275.60%18.78M

58.95%17.48M

--12.89M

--3.14M

--5.00M

--11.00M

----

营业收入

43.28%159.88M

49.81%148.93M

47.17%133.01M

64.09%127.78M

61.20%111.58M

42.93%99.41M

89.37%90.38M

107.68%77.88M

119.07%69.22M

149.24%69.55M

154.13%47.73M

114.46%37.50M

145.10%31.60M

789.29%27.91M

275.60%18.78M

58.95%17.48M

--12.89M

--3.14M

--5.00M

--11.00M

----

主营业务成本

25.14%28.80M

24.07%28.26M

22.74%25.54M

15.79%23.42M

29.10%23.02M

-8.95%22.78M

103.42%20.81M

196.93%20.23M

258.10%17.83M

456.74%25.02M

248.84%10.23M

169.89%6.81M

105.40%4.98M

136.15%4.49M

--2.93M

--2.52M

--2.42M

--1.90M

----

营业费用

75.95%223.04M

24.15%153.50M

26.53%130.41M

30.03%132.77M

32.48%126.77M

21.05%123.64M

41.43%103.06M

65.30%102.11M

62.89%95.69M

64.56%102.14M

41.06%72.87M

26.25%61.77M

28.75%58.75M

27.41%62.07M

8.03%51.66M

1.08%48.92M

-4.17%45.63M

31.83%48.71M

120.22%47.82M

105.12%48.40M

116.11%47.61M

98.04%36.95M

36.86%21.72M

68.14%23.60M

256.27%22.03M

--18.66M

--15.87M

--14.03M

--6.18M

研发费用

112.64%97.91M

16.08%51.11M

35.48%42.96M

41.00%46.07M

42.90%46.04M

42.32%44.03M

21.42%31.71M

48.45%32.67M

36.84%32.22M

-0.55%30.93M

-0.38%26.12M

-13.46%22.01M

-2.24%23.55M

11.99%31.11M

-13.96%26.22M

-27.44%25.43M

-36.83%24.09M

-6.56%27.77M

90.63%30.47M

88.89%35.05M

119.92%38.13M

106.72%29.73M

31.46%15.98M

60.11%18.55M

256.57%17.34M

--14.38M

--12.16M

--11.59M

--4.86M

折旧摊销及损耗

6.00%6.87M

-6.15%6.07M

-6.44%6.06M

-3.27%6.06M

6.70%6.49M

9.83%6.47M

110.84%6.48M

281.07%6.26M

354.60%6.08M

390.67%5.89M

180.38%3.07M

174.29%1.64M

290.94%1.34M

251.17%1.20M

1204.76%1.10M

658.23%599.00K

280.00%342.00K

302.35%342.00K

9.09%84.00K

12.86%79.00K

23.29%90.00K

44.07%85.00K

108.11%77.00K

62.79%70.00K

--73.00K

--59.00K

--37.00K

--43.00K

----

营业利润

-316.01%-63.16M

81.15%-4.57M

120.52%2.60M

79.41%-4.99M

42.64%-15.18M

25.67%-24.22M

49.56%-12.68M

0.17%-24.23M

2.50%-26.47M

4.61%-32.59M

23.52%-25.15M

22.80%-24.27M

17.07%-27.15M

25.04%-34.16M

23.22%-32.88M

15.94%-31.44M

31.25%-32.74M

-23.34%-45.58M

-97.20%-42.82M

-58.50%-37.40M

-116.11%-47.61M

-98.04%-36.95M

-36.86%-21.72M

-68.14%-23.60M

-256.27%-22.03M

---18.66M

---15.87M

---14.03M

---6.18M

净非营业利息收入（费用）

利息收入

12.50%3.40M

6.74%3.42M

-6.28%3.25M

-12.99%3.03M

-16.79%3.02M

-15.13%3.20M

-14.58%3.47M

-3.89%3.49M

59.90%3.63M

76.15%3.77M

200.37%4.06M

1137.88%3.63M

3192.75%2.27M

3196.92%2.14M

1777.78%1.35M

266.25%293.00K

-53.69%69.00K

-61.31%65.00K

-69.62%72.00K

-80.25%80.00K

-80.11%149.00K

-77.51%168.00K

-69.81%237.00K

-15.09%405.00K

222.84%749.00K

--747.00K

--785.00K

--477.00K

--232.00K

利息费用

-0.03%3.16M

0.53%3.60M

-11.80%3.16M

-11.40%3.16M

-11.57%3.16M

0.45%3.58M

0.34%3.59M

-4.21%3.57M

-15.68%3.58M

-18.26%3.56M

-10.00%3.57M

-3.85%3.73M

12.40%4.24M

15.75%4.36M

-29.93%3.97M

-18.87%3.88M

11.62%3.77M

1024.18%3.77M

--5.67M

--4.78M

--3.38M

1575.00%335.00K

----

--20.00K

--5.00K

----

--5.00K

出售证券收益

-4.85%-454.00K

----

---443.00K

---427.00K

---433.00K

----

特殊收入（费用）

---726.30M

--0.00

----

--0.00

100.00%0.00

----

-100.00%0.00

--0.00

-21253.45%-49.08M

----

-99.37%674.00K

-100.00%0.00

118.24%232.00K

-100.00%0.00

--106.85M

--1.35M

---1.27M

--334.00K

----

--0.00

----

--0.00

其他非经营性收入（费用）

-100.00%0.00

-194.37%-218.00K

136.34%395.00K

-72.44%86.00K

19.98%2.11M

107.55%231.00K

-182.22%-1.09M

213.87%312.00K

316.65%1.76M

-420.58%-3.06M

788.54%1.32M

-121.09%-274.00K

-426.62%-811.00K

-3358.82%-588.00K

-448.57%-192.00K

352.72%1.30M

-862.50%-154.00K

79.52%-17.00K

-16.67%-35.00K

-817.86%-514.00K

30.43%-16.00K

---83.00K

---30.00K

---56.00K

---23.00K

----

税前利润

-5686.05%-789.68M

79.63%-4.96M

119.03%2.64M

77.26%-5.46M

44.64%-13.65M

31.24%-24.37M

40.49%-13.89M

67.44%-24.00M

17.62%-24.66M

2.36%-35.43M

34.61%-23.34M

-120.12%-73.72M

18.22%-29.93M

-163.05%-36.29M

24.22%-35.69M

23.68%-33.49M

27.57%-36.59M

254.72%57.56M

-118.97%-47.10M

-88.76%-43.88M

-137.15%-50.53M

-107.47%-37.20M

-42.57%-21.51M

-71.48%-23.25M

-257.66%-21.31M

---17.93M

---15.09M

---13.56M

---5.96M

所得税

-53.84%475.00K

233.16%767.00K

-175.50%-262.00K

-36.69%402.00K

64.90%1.03M

-356.00%-576.00K

39.36%347.00K

100.95%635.00K

210.45%624.00K

60.71%225.00K

1815.38%249.00K

104.81%316.00K

1727.27%201.00K

1066.67%140.00K

44.44%13.00K

-59827.27%-6.57M

120.00%11.00K

500.00%12.00K

400.00%9.00K

266.67%11.00K

25.00%5.00K

-90.48%2.00K

---3.00K

--3.00K

--4.00K

--21.00K

----

除税后利润

-5283.63%-790.15M

75.91%-5.73M

120.41%2.90M

76.21%-5.86M

41.94%-14.68M

33.28%-23.79M

39.65%-14.23M

66.72%-24.64M

16.10%-25.28M

2.12%-35.66M

33.94%-23.59M

-175.01%-74.04M

17.69%-30.13M

-163.31%-36.43M

24.20%-35.71M

38.67%-26.92M

27.56%-36.61M

254.68%57.55M

-119.05%-47.11M

-88.78%-43.89M

-137.13%-50.53M

-107.24%-37.20M

-42.55%-21.51M

-71.51%-23.25M

-257.73%-21.31M

---17.95M

---15.09M

---13.56M

---5.96M

持续经营利润

-5283.63%-790.15M

75.91%-5.73M

120.41%2.90M

76.21%-5.86M

41.94%-14.68M

33.28%-23.79M

39.65%-14.23M

66.72%-24.64M

16.10%-25.28M

2.12%-35.66M

33.94%-23.59M

-175.01%-74.04M

17.69%-30.13M

-163.31%-36.43M

24.20%-35.71M

38.67%-26.92M

27.56%-36.61M

254.68%57.55M

-119.05%-47.11M

-88.78%-43.89M

-137.13%-50.53M

-107.24%-37.20M

-42.55%-21.51M

-71.51%-23.25M

-257.73%-21.31M

---17.95M

---15.09M

---13.56M

---5.96M

归属于母公司的净利润

-5283.63%-790.15M

75.91%-5.73M

120.41%2.90M

76.21%-5.86M

41.94%-14.68M

33.28%-23.79M

39.65%-14.23M

66.72%-24.64M

16.10%-25.28M

2.12%-35.66M

33.94%-23.59M

-175.01%-74.04M

17.69%-30.13M

-163.31%-36.43M

24.20%-35.71M

38.67%-26.92M

27.56%-36.61M

254.68%57.55M

-119.05%-47.11M

-88.78%-43.89M

-137.13%-50.53M

-107.24%-37.20M

-42.55%-21.51M

-71.51%-23.25M

-257.73%-21.31M

---17.95M

---15.09M

---13.56M

---5.96M

归属于普通股东的净利润

-5283.63%-790.15M

75.91%-5.73M

120.41%2.90M

76.21%-5.86M

41.94%-14.68M

33.28%-23.79M

39.65%-14.23M

66.72%-24.64M

16.10%-25.28M

2.12%-35.66M

33.94%-23.59M

-175.01%-74.04M

17.69%-30.13M

-163.31%-36.43M

24.20%-35.71M

38.67%-26.92M

27.56%-36.61M

254.68%57.55M

-119.05%-47.11M

-88.78%-43.89M

-137.13%-50.53M

-107.24%-37.20M

-42.55%-21.51M

-71.51%-23.25M

-257.73%-21.31M

---17.95M

---15.09M

---13.56M

---5.96M

基本每股收益

-4372.32%-13.43

77.49%-0.11

119.26%0.06

77.40%-0.12

44.27%-0.30

35.39%-0.49

48.09%-0.30

73.15%-0.52

32.64%-0.54

22.47%-0.76

43.86%-0.57

-132.12%-1.94

31.63%-0.80

-152.35%-0.99

34.10%-1.02

42.27%-0.84

30.32%-1.17

232.27%1.88

-81.29%-1.55

-55.90%-1.45

-95.18%-1.68

-82.66%-1.42

-30.54%-0.86

-57.89%-0.93

-232.28%-0.86

---0.78

---0.66

---0.59

---0.26

稀释每股收益

-4372.32%-13.43

77.49%-0.11

117.11%0.05

77.40%-0.12

44.27%-0.30

35.39%-0.49

48.09%-0.30

73.15%-0.52

32.64%-0.54

22.47%-0.76

43.86%-0.57

-132.12%-1.94

31.63%-0.80

-152.35%-0.99

34.10%-1.02

42.27%-0.84

30.32%-1.17

232.27%1.88

-81.29%-1.55

-55.90%-1.45

-95.18%-1.68

-82.66%-1.42

-30.54%-0.86

-57.89%-0.93

-232.28%-0.86

---0.78

---0.66

---0.59

---0.26

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Mirum Pharmaceuticals Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 MIRM 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Mirum Pharmaceuticals Inc 财年末的营收是多少？



Mirum Pharmaceuticals Inc 2025 财年营收为 521.31M，高于上一财年的336.89M。

Mirum Pharmaceuticals Inc 最近一个季度的营收是多少？



Mirum Pharmaceuticals Inc 最近一个季度的营收为 159.88M，同比增长 43.28%。

Mirum Pharmaceuticals Inc 全年的净利润是多少？



Mirum Pharmaceuticals Inc 2025 财年净利润为 -23.36M。

Mirum Pharmaceuticals Inc 上一季度的净利润是多少？



Mirum Pharmaceuticals Inc 最近一个季度的净利润为 -790.15M。

Mirum Pharmaceuticals Inc 年度营业利润是多少？



Mirum Pharmaceuticals Inc 2025 财年的营业利润为 -22.14M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。